- Regulation
- Technology
- Resources
Latest News
- Industry
Life Sciences
-
Amid calls of political favoritism, FDA continues to award national priority drug vouchers
In addition to questions from members of Congress, the program is facing scrutiny from medical organizations over whether it’s putting politics before science.